SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Themis Biosyn pays final settlement amount of Rs 31.00 lakh to GIIC

03 Apr 2014 Evaluate

Gujarat Themis Biosyn has paid an amount of Rs 31.00 lakh to Gujarat Industrial Investment Corporation (GIIC) as full and final settlement payment towards their unsecured loan of Rs. 26.00 lakh & Rs 5 lakh paid as goodwill. 

Earlier as on January 12, 2012, the BIFR directed GIIC to accept principal amount of unsecured loan of Rs. 26.00 lakh in three equal yearly installments commencing from April 01, 2011.

Gujarat Themis Biosyn’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×